Register to ALFA

Acute Leukemia French Association

The ALFA group (Acute Leukemia French Association) is a multidisciplinary association of clinicians, biologists, and clinical research assistants (Loi 1901 according to the French law) interested in the treatment of adult patients with Acute Myeloid Leukemia (AML) and conducting research works in this field.

alfa welcome image

Through a Board of Directors (CA) and a Scientific Committee (CS), both comprising clinician and biologist investigators, ALFA has the following objectives:

  • To initiate and promote any research in adult AML biology and treatment
  • To collect and manage the funds for this purpose
  • To support ALFA members in the acquisition of new competences and knowledge in the AML field
  • To diffuse knowledge and promote training in this field
  • To encourage and facilitate connections between the actors of AML patients’ care and research on AML, including universities, hospitals, private companies, charity structures and patients’ associations
  • To contribute to a better equipment and management of hospital clinical units and laboratories, as well as university research labs.
  • To support contacts with other national, European, and international cooperative groups or societies working in the AML field.
			welcome image

The means of action are:

  • The organization of periodic scientific or teaching meetings
  • The realization of clinical and biological research studies
  • The design, promotion, and coordination of its own clinical, biological, and therapeutically studies and trials
  • The participation in studies and trials from other cooperative groups
  • The analysis and publication of the results of these studies and trials (original articles, reviews, thesis…)
  • The participation in national and international conferences, workshops, and scientific meetings
  • The employment of assistant persons for study/trial monitoring or meeting organization.

You will find on this site:

  • The presentation and operation of the ALFA group
  • Information on the ALFA group members, as well as the ALFA studies and trials
  • Contacts and links towards useful sites and sites specialized in the AML field.

For ALFA group members, the "member access" tab allows access to the extranet site, which contains all documents to be shared (protocols, meeting dates, meeting reports, slideshows, working groups…).

The coordination
of the ALFA group is ensured by:

Its Board of Directors,
currently chaired by:
(Paris, Hôpital Saint-Louis, AP-HP)
(Lille, CHRU)
(Nice, Centre Antoine Lacassagne)
Its Coordination Office,
currently managed by:
(Paris, Hôpital Saint-Louis)
Dr Renaud BUFFET
(Paris, Hôpital Saint-Louis, AP-HP)

The legal location of ALFA is the Institut de Recherche Saint-Louis (IRSL), Département de Recherche de l’UFR de Médecine de l’Université de Paris, on the Hôpital Saint-Louis campus in Paris.

The ALFA group also includes some operational structures, like:

A centralized review of all conventional cytogenetic results coordinated by Dr Christine TERRE (Versailles, Hôpital André Mignot)

A centralized lab for molecular biology facilities and central review of all molecular results, including somatic gene mutation profiles and molecular measurable residual disease (MRD) monitoring, coordinated by Pr Claude PREUDHOMME (Lille, CHRU)

A central Biobank
(Lille, CHRU)

A laboratory network for flow cytometry (CMF) MRD, coordinated by Drs Adriana PLASA (Lyon, Hôpital Sud, HCL) and Christophe ROUMIER (Lille, CHRU)

An independent data center and biostatistical unit
Prs Sylvie CHEVRET and
(Paris, Hôpital Saint-Louis)

A laboratory network for translational studies, including Pr Raphaël ITZYKSON
(Paris, Hôpital Saint-Louis, IRSL)
and Dr Meyling CHEOK
(Lille, CHRU).